STA opening new transition metal catalysis center at API site

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/Sky_Blue)
(Image: iStock/Sky_Blue)

Related tags Catalysis Molecule

The new Changzhou, China-based site adds transition metal catalyst-screening technology to STA’s small molecule process development and manufacturing platform.

STA Pharmaceutical, a WuXi AppTec company, will launch the new center at its integrated API process R&D and manufacturing site in Changzhou, China.

According to the company, the facility will allow it to perform rapid screening of metal catalysts, ligands, bases, acids, chemical resolving reagents, and amide formation coupling reagents.

Additionally, the technology uses a parallel interactive testing approach, the company said.

STA is currently training a team of scientists specialized in the technology who will move to the Changzhou site when the center becomes fully operational in November.

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Related suppliers

Follow us

Products

View more

Webinars